Application of King’s Health Questionnaire in Urology Outpatient Clinic

Abstract

Objective: From simple to complex, there is a wide range of problems involving the bladder. One of the most distressing situations for patients is urinary incontinence. A lot of questionnaire studies were conducted to understand this situation which many patients who did not want to explain. We aimed to apply one of the world's most widely administered questionnaires, King 's Health Questionnaire (KHQ), to our patients. Materials and Methods: Between November and December 2010, for a period of one month, 171 female patients applying to urology outpatient clinic for the first time with any complaints, were agreed to fill out KHQ. This survey is mainly composed of 9 questions. We divided the patients into two groups according to the second question which evaluates incontinence effect (the first group with no or mild complaints, the second group with moderate or severe complaints), and comparisons were made accordingly. Statistical analysis was performed by Pearson's chi-square and Student's t-tests, and p<0.05 was considered significant. Results: Excluding the question of personal relationship (p=0.109), significant differences were observed between two groups in terms of all the other questions (p <0.01). Conclusion: We think that, KHQ can be applied to all female patients of any age regardless of their complaints. It is a short and easly understandable questionnaire and patients can fill out it without guidance. Key words: İncontinence; King's Health Questionnaire; Quality of Life.

Keywords

• İncontinence; King's Health Questionnaire; Quality of Life.

Üroloji Polikliniğinde King Sağlık Anketi Uygulaması

Öz

Amaç: Mesaneyi ilgilendiren basitten karmaşığa birçok sorun vardır. Hastalar için en sıkıntılı durumlardan biri üriner inkontinanstır. Birçok hastanın açıklamak istemediği bu durumu anlamaya yönelik birçok anket çalışması yapılmıştır. Biz de dünyada en çok uygulanan anketlerden biri olan King Sağlık Anketi (KSA)'ni hastalarımıza uygulamayı amaçladık. Materyal ve Metot: Kasım ile Aralık 2010 arasında 1 ay süre ile üroloji polikliniğimize ilk defa herhangi bir şikayetle başvuran 171 kadın hasta KSA'ni doldurmayı kabul etti. Bu anket asıl olarak 9 sorudan oluşmaktadır. Biz anketin inkontinans etkisini değerlendiren ikinci sorusuna göre hastaları iki gruba ayırdık (hiç ya da az şikayeti olan ilk grup, orta ya da çok şikayeti olan ikinci grup) ve karşılaştırmaları buna göre yaptık. İstatistiksel değerlendirmeler Pearson ki-kare ve Student t-testleri ile yapıldı ve çalışmada anlamlılık düzeyi p<0.05 olarak kabul edildi. Bulgular: Kişisel ilişki sorusu hariç (p=0.109) diğer tüm sorular açısından gruplar arasında anlamlı fark saptandı (p<0.01). Sonuç: Başvuru şikayetine bakılmaksızın her yaştan kadın hastaya KSA'nin uygulanabileceğini ve bu anketin kolay anlaşılabilir, kısa ve hastaların tek başına doldurabileceği bir anket olduğunu düşünmekteyiz. Anahtar kelimeler: İnkontinans; King Sağlık Anketi; Hayat Kalitesi.

Anahtar Kelimeler

• İnkontinans; King Sağlık Anketi; Hayat Kalitesi.

References

1. Thom DH. Overactive bladder: Epidemiology and impact on quality of life. Patient Care 2000; Winter Suppl: 6-14.
2. Wein AJ, Rovner ES. The overactive bladder: An overview for primary care health providers. Int J Fertil 1999;44:56-66.
3. Abrams P, Cardozo L, Fail M, Griffiths D, Rosier P, Ulmsten U, Kerrebroeck P, Victor A, Wem A. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international Continence Society. Neurourology and Urodynamics 2002;21:167-178.
4. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisation of terminology of lower urinary tract function. Br J Obstet Gynaecol 1990;97:1-16.
5. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalance of urinary incontinence. Br Med J 1980;281:1243-5.
6. Herzog AR, Fultz NH. Prevalance and incidence of urinary incontinence in community dwelling populations. J Am Geriatr Soc 1990;38:273-281.
7. Maral I, Özkardeş H, Peskircioğlu L,Bumin MA. Prevalence of stress urinary incontinence in both sexes at or after age 15 years: a cross-sectional study. J Urol 2001;165:408-12.
8. Özerdoğan N, Beji NK, Yalçın O. Urinary incontinence: its prevalance, risk factors and effects on the quality of life of women living in a region of Turkey. Gynecol Obstet Invest ;58:145-50. Buchsbaum GM, Chin M, Glantz C, Guzick D. Prevalence of urinary incontinence and associated risk factors in a cohort of nuns. Obstet Gynecol 2002;100:226-9.

9. Simeonova Z, Milsom I, Kullendorff AM, Molander U, Bengtsson C. The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population. Acta Obstet Gynecol Scand 1999;78:546
10. Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA. Psychosocial impact of urinary incontinence in women. Obstet Gynecol 1987;70(3 Pt 1):378-81.
11. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 1995;14(2):131-9.
12. Raz S and Erickson DR. SEAPI QMM incontinence classification system. Neurourol Urodyn 1992;11:187-92.
13. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997;104:1374-9.
14. Kwon BE, Kim GY, Son YJ, Roh YS, You MA. Quality of life of women with urinary incontinence: a systematic literature review. Int Neurourol J 2010 Oct;14(3):133-8.
15. Aslan E, Beji NK, Erkan HA, Yalcin O, Gungor F. Urinary incontinence (UI) and quality of life (QoL) of the elderly residing in residential homes in Turkey. Arch Gerontol Geriatr ;49(2):304-10. Arikan, E, Ozcan, E, Bardak, A, Ketenci A. Urinary incontinence in women living in a rest home. Turkish J. Geriatri 2002;5:7-10 (in Turkish).
16. Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the patient perception of bladder condition (PPBC): a singleitem global measure for patients with overactive bladder. Eur Urol 2006, 49(6):1079-86.
17. Grimby, A, Milsom I, Molander U, Wiklund I, Ekelund P. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 1993; 22:82-9.
18. Minossion VA, Drutz HP, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Gynecol Obstetr 2003;82:327-8.
19. Wyman, JF, Fantl, JA, McClish, DK, Bump RC. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. Am J Obstet Gynecol 1998;179:999-1007.
20. Reese PR, Pleil AM, Okano GJ, Kelleher CJ. Multinational study of reliability and validity of the King’s Health Questionnaire in patients with overactive bladder. Qual Life Res 2003;12:427-42.
21. Espuña Pons M, Puig Clota M. Coital urinary incontinence: impact on quality of life as measured by the King’s Health Questionnaire Int Urogynecol J 2008;19:621-5.
22. Ternent L, Vale L, Buckley B, Glazener C. Measuring outcomes of importance to women with stress urinary incontinence. BJOG 2009;116(5):719-25.
23. Dwyer P, Kelleher C, Young J, Haab F, Lheritier K, Ariely R, Ebinger U. Long-Term Benefits of Darifenacin Treatment for Patient Quality of Life: Results from a 2-year extension study Neurourology and Urodynamics 2008;27:540-7.
24. Van Kerrebroeck PEV, Kelleher CJ, Coyne KS, Kopp Z, Brodsky M, Wang JT. Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo. Health and Quality of Life Outcomes 2009;(18);7:13.
25. Homma Y, Kawabe K. Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial World J Urol 2004;22:251
26. Dmochowski RR, Rosenberg MT, Zinner NR, Staskin DR, Sand PK. Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder. Value Health ;13(2):251-7. Colman S, Chapple C, Nitti V, Haag-Molkenteller C, Hastedt C, Massow U. Validation of Treatment Benefit Scale for Assessing Subjective Outcomes in Treatment of Overactive Bladder. Urology 2008;72(4):803-7.
27. Kelleher CJ, Reese PR, Pleil AM, Okano GJ Healthrelated quality of life of patients receiving extended release tolterodine for overactive bladder. Am J Man Care 2002;8 Suppl]:608-15
28. Pleil AM, Reese PR, Kelleher CJ, Okano GJ. Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine. Health Econ Prev Care ;2:69-75
29. Kim SH, Oh SJ. Comparison of voiding questionnaires between female interstitial cystitis and female idiopathic overactive bladder. Int Neurourol J 2010;14(2):86-92.
30. Kikuo Okamura, Yoshikatsu Nojiri and Yoko Osuga Reliability and validity of the King’s Health Questionnaire for lower urinary tract symptoms in both genders BJU Int ;103:1673-8.